---
schema_version: "secwatch.filing_event.v1"
accession: "0001613103-21-000070"
form_type: "8-K"
ticker: "MDT"
cik: "0001613103"
company_name: "Medtronic plc"
filed_at: "2021-12-16T23:59:59+00:00"
generated_at: "2026-06-28T00:32:35.799577+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Chief Medical & Scientific Officer Richard Kuntz to retire April 29, 2022

## Summary
- Richard Kuntz notified Medtronic on Dec 14, 2021 of retirement effective April 29, 2022.
- Kuntz served as SVP and Chief Medical & Scientific Officer and on executive committee since 2005.
- He leaves after over 15-year tenure at Medtronic and 40-year career as interventional cardiologist.
- Filing does not name a successor or interim replacement for the role.

## SEC filing metadata
- accession: 0001613103-21-000070
- form_type: 8-K
- ticker: MDT
- cik: 0001613103
- company_name: Medtronic plc
- filed_at: 2021-12-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000070/0001613103-21-000070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000070/mdt-20211214.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001613103-21-000070
- JSON: https://secwatch.observer/filing/0001613103-21-000070.json
- Plain text: https://secwatch.observer/filing/0001613103-21-000070.txt

## Key facts
- Executive change
  Richard Kuntz retired as Senior Vice President and Chief Medical and Scientific Officer at Medtronic plc.
  - Action: retired
  - Role: Senior Vice President and Chief Medical and Scientific Officer
  source text: On December 14, 2021, Richard Kuntz, M.D. notified Medtronic plc (the “Company”) that he had decided to retire as Senior Vice President and Chief Medical and Scientific Officer of the Company, effective as of April 29, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000070/0001613103-21-000070-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.